Chris Molloy

Chris Molloy has a 30-year international board and executive career across life sciences R&D. Following a 14 year career in large pharma, Chris was COO of the Singaporean biotech, MerLion Pharmaceuticals; then led corporate development for the global informatics specialist idbs. Chris spent three years as CEO of the RSA Group, the life science executive search firm and is the founding CEO of the UK’s Medicines Discovery Catapult. Chris is the non-executive chairman of Exploristics Ltd: a private UK tech company using statistical simulations to improve success rates in clinical development. He chairs the IP Advisory Committee for the Association of Medical Research Charities and the Industry Advisory Board for Manchester’s Biomedical Research Centre & Health Innovation Manchester. Chris holds personal US and EU patents in HIV drug discovery, is a Member of the Institute of Cancer Research and holds an honorary chair at the University of Manchester.